# AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

> **NCT06035250** · — · RECRUITING · sponsor: **Chinese Academy of Sciences** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer
- Image
- Pathology

## Interventions

- **DRUG:** Neoadjuvant Chemotherapy

## Key facts

- **NCT ID:** NCT06035250
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-10
- **Primary completion:** 2024-08-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06035250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06035250, "AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06035250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*